Notice of the extraordinary general meeting
Filed with HKEX · Stock code 1541 · · 2 pages · English
Summary by 6ix AI
This filing is a notice for an Extraordinary General Meeting of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. The meeting will address the appointment of a new Independent Non-Executive Director and the proposed changes in the company's auditor. Shareholders are entitled to appoint proxies to vote on their behalf. The notice includes details on the voting process and requirements for attending the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
ImmuneOnco Biopharmaceuticals (Shanghai) Inc on 6ix
Earlier from ImmuneOnco Biopharmaceuticals (Shanghai)
- Next Day Disclosure Return
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October, 2026
- Proposed change of auditor
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September, 2026
- Voluntary announcement - completion of capital Increase of a subsidiary
Later from ImmuneOnco Biopharmaceuticals (Shanghai)
- (1) Appointment of independent non-executive director; (2) proposed removal of auditor; (3) proposed appointment of auditor; and (4) notice of extraordinary general meeting
- Proxy Form for the Extraordinary General Meeting to be held on Wednesday, December 9, 2026
Follow ImmuneOnco Biopharmaceuticals (Shanghai) into a list and get an email when it puts out news.
Follow ImmuneOnco Biopharmaceuticals (Shanghai)